Skip to content

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Contemporary Fibrotic Interstitial Lung Disease Outcomes: A Multicentre National Cohort Study.

BACKGROUND AND OBJECTIVE This study determined contemporary transplant-free survival in fibrotic interstitial lung disease (ILD), identified baseline factors associated with death or transplant, and assessed performance of the ILD-GAP (Gender, Age, Physiology) index in a contemporary cohort. METHODS Patients with idi...

T. Pitre, C. Ryerson, S. Ong et al. · 0 citations
Review Sep 2026

The emerging role of PDE4 inhibitors for the treatment of pulmonary fibrosis

ABSTRACT Introduction Nerandomilast, a phosphodiesterase-4B (PDE4B) preferential inhibitor, was approved in 2025 for the treatment of idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF). PDE4 enzymes play a central role in regulating intracellular cyclic adenosine monophosphate (cAMP) and are h...

A. Tyker, N. Kuse, B. Pertzov et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.